Moderna announced Monday that its studies have shown the company’s COVID-19 vaccine remains effective against emerging variants of the virus first identified in the United Kingdom and South Africa.The Massachusetts-based company, which makes one of the two vaccines currently authorized for emergency use by the FDA, said in a statement that the two variants were tested against sera from individuals who had been inoculated with